Skip to content

Psychosomatic Factors Influencing the Efficacy of Holistic Care for Migraine

Exploring the Psychosomatic Factors Influencing and Moderating the Efficacy of Holistic Care and Personalized Treatment for Migraine Patients: A Prospective Longitudinal Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06334237
Enrollment
120
Registered
2024-03-27
Start date
2024-04-18
Completion date
2026-02-21
Last updated
2024-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Keywords

migraine, holistic care, personalized treatment

Brief summary

This research project aims at exploring the psychosomatic factors that influence and moderate the efficacy of holistic care and personalized treatment for migraine patients. It is a prospective longitudinal observational study. The project's goal is to understand how physical, psychological, spiritual, and social factors affect the care and treatment outcomes for migraineurs. The study will include participants aged 18 to 65, who meet the International Headache Society's criteria for migraines. It will utilize a range of methodologies including questionnaires, interviews, and medical records to collect data on various factors like lifestyle, psychological state, and social support. The project will assess the effectiveness of treatments, compliance, and other outcomes such as emotional and sleep conditions.

Detailed description

In this study, participants will be recruited through clinics. All the participants will be asked to keep a migraine diary for the duration of three months. In addition to that, the participants will fill out questionnaires that measures depression, anxiety, well-being and migraine related disability. This study does not intervene with the routine clinical care. The investigators merely observe through participant's diary and other patient reports to find out about how psychological and social factors might lead to different clinical outcomes.

Interventions

According to the condition of each individuals, the study continues their routine clinical care. The study does not offer anything more than a routine clinical care. It is named personalized treatment because the condition of each individual varies, so the doctor may prescribe or offer clinical advice accordingly. .

Sponsors

Changhua Christian Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* individuals aged between 18 and 65 who meet the International Headache Society's criteria for migraines

Exclusion criteria

* incapacitate such as dementia or cognitive deficiency * illiterate, or could not sign informed consents * severe disorder or co-morbidities that the doctors advice against participation

Design outcomes

Primary

MeasureTime frameDescription
Migraine attack frequency3 monthsThe frequency of migraine attacks will be assessed by the number of days with migraine attacks recorded in the migraine diary.
Migraine attack intensity3 monthsThe intensity of migraine attacks will be assessed by the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst pain imaginable). Higher scores indicate greater pain intensity.
Migraine attack duration3 monthsThe duration of each migraine attack will be recorded in the migraine diary, measured in hours.
Effectiveness of acute medication3 monthsThe effectiveness of acute medication will be assessed by a 4-point scale measuring the degree of pain relief after medication administration, recorded in the migraine diary: 1. No effect at all 2. Minimal effect, headache slightly improved 3. Good effect, headache significantly improved 4. Very effective, pain completely resolved

Secondary

MeasureTime frameDescription
well-being3 monthsWell-being will be assessed by the Flourishing Scale. The scale ranges from 8 to 56, with higher scores indicating greater psychological well-being.
Compliance rate of migraine diary3 monthsThe compliance rate of migraine diary will be calculated as the percentage of days with appropriately completed diary entries out of the total days of participation.
Pain Resilience3 monthsPain resilience will be assessed by the Pain Resilience Scale (PRS). The scale ranges from 0 to 56, with higher scores indicating greater resilience to pain.
Compliance rate of lifestyle modification3 monthsThe compliance rate of lifestyle modification will be assessed by self-reported adherence to recommended changes (e.g., sleeping time, or exercising) in the migraine diary.
depression3 monthsDepression will be assessed by the Patient Health Questionnaire-9 (PHQ-9). The scale ranges from 0 to 27, with higher scores indicating more severe depression.
anxiety3 monthsAnxiety will be assessed by the Generalized Anxiety Disorder-7 (GAD-7). The scale ranges from 0 to 21, with higher scores indicating more severe anxiety.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026